TAYLOR & FRANCIS AWARDS

Past years' winners

Clin Tox

Taylor & Francis
Clinical Toxicology


The Taylor & Francis Awards


The Taylor & Francis Awards are offered two the Best Case Report and the Best Scientific Presentation.




Since 2008 Taylor & Francis offers two awards for the Best Case Report and the Best Scientific Presentation.

Any original submission to the meeting of a) a scientific presentation of b) a single case report or a small number of cases, via the usual abstract submission process can be considered for these awards, except for invited keynote or plenary lectures and those that have already been short-listed for the Young Investigator's Award. There are no restrictions on age and authors do not have to be EAPCCT members.

All original submitted abstracts are subject to a blinded reviewing process involving at least eight separate reviewers. Accepted abstracts are short-listed on the basis of the eligibility criteria and overall mean quality scores provided by teh reviewers. Short listed authors are informed in advance of the meeting. The winners are chosen by a panel of at least three judges. Their decision will be final.

Winners will be awarded a certificate, expedited publication of their presentation in Clincal Toxicology (subject to acceptance via the usual manuscript review process) and 500 USD.


2019 Winners


Best Scientific Presentations:

Butanediol conversion to gamma-hydroxybuty-rate markedly reduced by the alcohol dehydro-genase blocker fomepizole.
Liakoni E (1,2), Gugelmann H (3), Dempsey DA (1), Wiegand TJ (4), Havel C (1), Jacob P (1), Benowitz NL (1,3,5).
1. Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, University of California, San Francisco, United States;
2. Clinical Pharmacology and Toxicology, Department of General Internal Medicine Inselspital, Bern Uni-versity Hospital, University of Bern, Bern, Switzerland;
3. California Poison Control Center, University of Cali-fornia, San Francisco, United States;
4. University of Rochester Medical Center, Rochester, United States;
5. Department of Bioengineering and Therapeutic Sci-ences, University of California, San Francisco, United States.

Using EXTRIP criteria as indications for extra-corporeal treatment in lithium poisoning.
Chan BS (1), Cheng S (2), Chiew AL (1), Buckley NA (3).
1. Department of Emergency Medicine & Clinical Toxicology, Prince of Wales Hospital, Sydney, Australia;
2. Faculty of Medicine, University of New South Wales, Sydney, Australia;
3. Department of Clinical Pharmacology, University of Sydney, Sydney, Australia.

Best Case Reports:

Verification of diazinon poisoning of a 5-year-old Boy.
Siegert M (1), Finter J (2), Koller M (1), Thiermann H (1), John H (1)
1. Bundeswehr Institute of Pharmacology and Toxicology, Munich, Germany;
2. University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Severe suicidal self-poisoning with massive dose of potassium ferricyanide: risk of life-threating hyperkalemia and acute renal failure.
Pelclova D (1), Zdimal V (2), Vlckova S (1), Fenclova Z (1), Lischkova L (1).
1. Department of Occupational Medicine, Charles Uni-versity in Prague and General University Hospital, First Faculty of Medicine, Prague, Czech Republic;
2. Institute of Chemical Process Fundamentals of the CAS, Prague, Czech Republic.